Study of Oral Venetoclax Tablets in Combination With Intravenous Obinutuzumab Injection to Assess Achievement of Best Response in Adult Participants With Chronic Lymphocytic Leukemia
Clinical trial NCT04655261 · TERMINATED
Trial details
- NCT number
- NCT04655261
- Sponsor
- AbbVie
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2020-12-12
- Primary completion
- 2021-11-09
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.